Searched for
MERCK AND CO
Stocks in news: Rajesh Exports, Lenskart, Suzlon Energy, Aurobindo Pharma, Tata MotorsIndian markets saw volatility and closed lower on Wednesday. Key companies are in focus due to significant developments. SoftBank reduced i...
Aurobindo Pharma enters biologics contract manufacturing with Rs 1,200-crore Telangana facilityAurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic medicines f...
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
Ebola outbreak sparks concern in India, US: Should you be worried? Here's what you need to know about signs, symptoms and preventionEbola in India: The WHO has declared the Ebola outbreak in Congo and Uganda a public health emergency with over 300 cases and 88 deaths. In...
US stock market today: Dow Jones crashing today while the Nasdaq and S&P 500 hitting record highsThe Dow Jones is crashing as Nasdaq and S&P 500 hit record highs amid AI stock surge. The U.S. stock market today looks confusing at first ...
Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages saySun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in...
Sun Pharma to buy Organon in $11.75 billion all-cash dealSun Pharmaceutical Industries has agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately $11.75 billion,...
Merck to partner with Google Cloud on AI initiativesDrugmaker Merck & Co is joining forces with Google Cloud. They will invest up to one billion dollars over several years. This partnership a...
Merck wants to give products to Indians at affordable prices: Kenneth Frazier, Merck & CO"I see the progress made by the Modi administration towards not only ensuring that India can meet the needs of its people in healthcare, bu...
Merck & Co to expand in India, favourable IPR ruling encourages co to invest moreThe Delhi High Court decision on its anti-diabetes drug Januvia is among the factors encouraging Merck to invest in India, global CEO Kenne...
Sun Pharmaceutical, Merck & Co call off 2011 JV: SourcesSun Pharma & US-based Merck & Co have called off their more than three-year-old joint venture that aimed to bring innovative drugs to emerg...
Sun Pharmaceutical shares end nearly 2 per cent up on Merck & Co Inc licensing pactStock of the pharma firm settled with a gain of 1.63 per cent at Rs 805.20 on the BSE. During the day, it climbed 2.78 per cent to Rs 814.4...
Aurobindo Pharma gets USFDA final nod for migraine tabletsAurobindo Pharma today said it has received final approval from the US health regulator to manufacture Rizatriptan Benzoate tablets.
- Merck, Ranbaxy drug development deal called off
US drug maker Merck & Co has terminated its nearly two-year-old alliance with Ranbaxy Laboratories to develop anti-infective medicines, whi...
- Merck ends pact with Ranbaxy
Separate reports have said the world's 2nd largest drugmaker has now shifted the research programme to Aurigine, a wholly-owned drug discov...
- Merck to acquire SmartCells for USD 500 mn
Drug-maker Merck & Co has announced that it will buy biotechnology company SmartCells for USD 500 million.
- Merck's 2Q net drops on higher costs, charges
Drugmaker Merck & Co. posts a 52 percent drop in second-quarter net income, due to higher costs for sales, administration and restructuring...
- Merck may slash 15% of global workforce; shut research sites
Global healthcare major Merck & Co is planning to close 16 research and manufacturing sites worldwide and slash 15 per cent of its workforc...
- Merck, Glenmark end cholesterol drug row
Cos opt for out-of-court settlement; Merck to refund $20-mn litigation costs.
- Merck & Co signs global multi-services pact with HCL Tech
IT firm HCL Technologies Ltd on Tuesday announced a multi-year, multi-service agreement with Merck & Co Inc, expanding upon the existing re...